Share

Archive for November 2014

Medical Mysteries: Doctors puzzled by woman’s dizziness and amplified body sounds

Posted by Kerrie Denner

By Sandra G. Boodman, Washington Post, November 24, 2014

‘That’s it — I’m done,” Rachel Miller proclaimed, the sting of the neurologist’s judgment fresh as she recounted the just-concluded appointment to her husband. Whatever was wrong with her, Miller decided after that 2009 encounter, she was not willing to risk additional humiliation by seeing another doctor who might dismiss her problems as psychosomatic.

Otonomy obtains rights to data to support development of a treatment for tinnitus

Posted by Kerrie Denner

Otonomy, Inc. (Nasdaq: OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, and Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, today announced that they have entered into an exclusive licensing agreement enabling Otonomy to utilize Ipsen's gacyclidine data in the development and registration of OTO-311.

Did this information help you? 

 

Join VEDA's email list to receive the latest news & updates! 

Sign me up! No, thanks